
ENDEDLive coverage has endedEnded: October 25, 2025, 6:00 AM EDT West Pharmaceutical Services Q3 Profit Beats Estimates, Raises FY25 Guidance (WST) October 23, 2025, 7:22 AM EDT. West Pharmaceutical Services (WST) reported a **Q3 profit** of $140.0 million, or $1.92 per share (GAAP), up from $136.0 million, $1.85 a year earlier. Excluding items, **adjusted earnings** rose to $142.4 million, or $1.96 per share, versus consensus of about $1.69. **Revenue** climbed 7.7% to $804.6 million from $746.9 million. Looking ahead, the company issued **next-quarter guidance** of $1.81-$1.86 for **EPS** and $790-$800 million for **revenue**. For FY25, West raised its **adjusted-diluted EPS
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
Policy tone can move rates, USD, equities, gold and crypto simultaneously.
A weak final reading or elevated inflation expectations could pressure risk assets.
A surprise versus 58.0 may alter the near-term manufacturing-growth narrative.